Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001221508-11-000015
Filing Date
2011-10-19
Accepted
2011-10-19 16:54:45
Documents
9
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-KA AMENDMENT NO 2 form10ka_06302011.htm 10-K/A 23791
2 EXHIBIT 31.1 ex311a_june302011.htm EX-31 7815
3 EXHIBIT 31.2 ex312a_june302011.htm EX-31 7722
4 EXHIBIT 32 ex32a_june302011.htm EX-32 3920
  Complete submission text file 0001221508-11-000015.txt   1037021

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE mlph-20110630.xml EX-101.INS 224699
6 XBRL SCEMA FILE mlph-20110630.xsd EX-101.SCH 7121
7 XBRL DEFINITION FILE mlph-20110630_def.xml EX-101.DEF 11590
8 XBRL LABEL FILE mlph-20110630_lab.xml EX-101.LAB 73956
9 XBRL PRESENTATION FILE mlph-20110630_pre.xml EX-101.PRE 48502
Mailing Address SUITE 1023 8721 SANTA MONICA BOULEVARD LOS ANGELES CA 900694507
Business Address DRUG DISCOVERY RESEARCH CENTRE 284 OXFORD STREET, LEEDERVILLE 6007 PERTH, WESTERN AUSTRALIA C3 00000 011-61-8-9443-3011
Molecular Pharmacology (USA) Ltd. (Filer) CIK: 0001191357 (see all company filings)

EIN.: 710900799 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 000-50156 | Film No.: 111148500
SIC: 2834 Pharmaceutical Preparations